Health & Fitness:Medicine
A recently published study explores the possible benefits to discontinuing an alpha-1 blocker after receiving combination therapy with a 5-alpha reductase inhibitor for the treatment of benign prostatic hyperplasia (BPH). In more symptomatic patients, or patients with confirmed, enlarged prostates, it is recommended to use both medication classes (alpha-1 blocker and 5-alpha reductase inhibitor) to minimize symptoms by relaxing the prostatic smooth muscle and reducing the size of the prostate – producing a potentially synergistic effect. This study found that withdrawal of alpha 1-blockers after a year of combination therapy did not worsen urinary symptoms, QOL, and voiding or storage function. This provides evidence that combination therapy may not be needed indefinitely for all patients.
Guest Authors: Erica Crannage, PharmD and Stephanie Crist, PharmD
Music by Good Talk
Bursting the Steroid Bubble: Short-term Use Has Its Consequences
Guiding Antiplatelet Therapy: Is a Personalized Approach Worth It?
Psilocybin for Depression: Is it Worth the Trip?
Up the Creek Without a Paddle? Look to Your Pharmacist to Bridge-It
SGLT2i plus MRAs for Heart Failure: A Sweet or Sour Combination?
Is As-Needed Nasal Corticosteroid Use Needed for Allergic Rhinitis Management?
STEP-ping Up the Game for Weight Management
Raised From The Grave: A Second Life for Sotagliflozin?
Tiny (n-of-1) Trials to Overcome Statin-Associated Muscle Pain
Top Ten Things Every Clinician Should Know About Infographics
Mind Over Migraine: Can Mindfulness Improve Outcomes?
Is Home Blood Pressure Monitoring a “Home Run” for Blood Pressure Management?
Increasing the Patient-Clinician Connection: the “Presence 5 Practices”
FAST Take: Update on Febuxostat Cardiovascular Safety
Metformin During Pregnancy: Are the Results MiTy Enough to Change Practice?
Can a Polypill ‘TIP’ the Scale to a One-Size-Fits All Approach?
There’s an App for That! Can Smartphone Apps Assist with Smoking Cessation?
DECLARE-ing Another Victory for Dapagliflozin
Closing the Loop for Children with Type 1 Diabetes
Is it Time to Add Colchicine to the CVD Cocktail?
5 Minute Sono
Men in Lead Aprons
THE MCCULLOUGH REPORT
The Doctor‘s Farmacy with Mark Hyman, M.D.
Copyright © 2006-2021 Podbean.com